Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bradley Strnad

Diagnostic Radiology Fort Wayne, IN Medical Doctor

NPI 1548263726 CMS profile 205437

7900 W Jefferson Blvd Ste 104, Fort Wayne, IN 46804

Open in the dashboard

General payments

$40,217

400 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bradley Strnad of Fort Wayne, IN is reported in the CMS Open Payments database as having received $40,217 across 400 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,559 95
2024 General $11,833 94
2023 General $6,420 71
2022 General $1,751 27
2021 General $1,823 24
2020 General $1,915 25
2019 General $4,916 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bradley Strnad
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Bradley Strnad were reported at $11,559. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Bradley Strnad Diagnostic Radiology median Middle half National median
2019 $4,916 $108 $29–$318 $163
2020 $1,915 $65 $21–$252 $114
2021 $1,823 $92 $24–$292 $132
2022 $1,751 $104 $29–$294 $149
2023 $6,420 $110 $29–$337 $160
2024 $11,833 $113 $30–$356 $164
2025 $11,559 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $16,908 142 payments
  2. Medtronic, Inc. $7,576 84 payments
  3. Reflow Medical Inc $3,172 19 payments
  4. Inari Medical, Inc. $2,934 12 payments
  5. Medtronic USA, Inc. $2,020 24 payments
  6. AngioDynamics, Inc. $1,613 14 payments
  7. Nevro Corp. $1,403 12 payments
  8. Shockwave Medical, Inc $1,120 31 payments
  9. Penumbra, Inc. $670 14 payments
  10. Terumo Medical Corporation $625 8 payments
  11. Other $2,177 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $22,262 333 payments
  2. Travel and Lodging $17,087 64 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $500 1 payment
  4. Long term medical supply or device loan $333 1 payment
  5. Education $35 1 payment
Products named General payments · program years 2019–2025
  1. KYPHON EXPRESS II KYPHOPAK TRAY $4,085 40 payments
  2. General - Vascular Intervention $3,282 20 payments
  3. FLOWTRIEVER CATHETER, S $2,983 12 payments
  4. EkoSonic $2,707 8 payments
  5. CT THROMBECTOMY SYSTEM KIT $2,685 10 payments
  6. KYPHON Balloon Kyphoplasty $2,020 24 payments
  7. OSTEOCOOL RF ABLATION SYSTEM $1,834 25 payments
  8. Senza $1,403 12 payments
  9. OBSIDIO $1,353 7 payments
  10. AURYON LASER SYSTEM 100-120 VAC $1,159 8 payments
  11. Other $13,017 194 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 134 billing codes

Paid by Medicare

$58,587

Medicare's payments for the services billed

Medicare patients

579

Average age 74

Services billed

975

288 women, 291 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Ischemic heart disease 48%
Chronic kidney disease 46%
Diabetes 45%
Heart failure 36%
COPD 34%
Atrial fibrillation 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

400 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record